Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
To cover taxesNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Jan 2026 and Mar 2026.
- Largest single sale: $1.6M (15,000 shares) of Protagonist Therapeutics, Inc on Mar 26, 2026. Filing
- Last sale before this period: Jun 10, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | Chief Medical Officer | Nov 17, 2022 | Mar 27, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Mar 26, 2026, Protagonist Therapeutics, Inc: sold 15,000 shares for $1.6M, no plan disclosed; 15,000 shares acquired by exercising options. 1 filing: 1
- Jan 27, 2026, Protagonist Therapeutics, Inc: sold 5,000 shares for $410K, no plan disclosed; 5,000 shares acquired by exercising options. 1 filing: 1
- Jan 26, 2026, Protagonist Therapeutics, Inc: sold 5,000 shares for $411K, no plan disclosed; 5,000 shares acquired by exercising options. 1 filing: 1
- Jan 23, 2026, Protagonist Therapeutics, Inc: sold 13,151 shares for $1.1M, no plan disclosed. 1 filing: 1
- Jan 20, 2026, Protagonist Therapeutics, Inc: sold 9,514 shares for $785K, to cover taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.